Status:
COMPLETED
HPV in Sentinel Lymph Nodes of Cervical Cancer Patients
Lead Sponsor:
University of Aarhus
Conditions:
Cervical Cancer
Sentinel Lymph Node
Eligibility:
FEMALE
18+ years
Phase:
NA
Brief Summary
This study examines sentinel lymph node tissue from early stage cervical cancer patients treated with radical surgery and removal of pelvic sentinel lymph nodes (SLN). SLNs are tested for the presence...
Detailed Description
The aim of the study is to examine whether the pathologic status of SLNs in patients with early-stage cervical cancer correlates to the HPV status in the SLNs and also, whether cervical cancer recurre...
Eligibility Criteria
Inclusion
- Woman \> 18 years of age diagnosed with cervical cancer and admitted for surgery with radical hysterectomy and removal of SLNs between October 2018 and June 2022.
Exclusion
- Woman \< 18 years
- Women with late-stage cervical cancer, who are treated with radio- and chemotherapy.
Key Trial Info
Start Date :
October 1 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 31 2023
Estimated Enrollment :
127 Patients enrolled
Trial Details
Trial ID
NCT03749707
Start Date
October 1 2018
End Date
December 31 2023
Last Update
April 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Obstetrics and Gynecology
Aarhus, Denmark, 8200